Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The NIH announcement banner about terminology changes has been removed. The page’s study-record error content is otherwise unchanged.
    Difference
    1%
    Check dated 2026-11-08T14:52:35.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The displayed site revision updates from v3.7.2 to v3.8.0, while the study record continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:57:49.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T19:50:09.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page; its footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:48:05.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:56:25.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the previous detailed study record and navigation. This blocks access to the trial information and related resources on that page.
    Difference
    20%
    Check dated 2026-09-20T22:50:07.000Z thumbnail image

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.